Skip to main content

Table 5 Direct screening of the antimicrobial susceptibilities of certain Pseudomonas spp. by the VITEK AST GN83 cards

From: Pseudomonas species prevalence, protein analysis, and antibiotic resistance: an evolving public health challenge

Antimicrobial agent Percentage of antimicrobial resistance of Pseudomonas spp. Total
(n = 69)
P. lundensis
(n = 18)
P. fragi
(n = 16)
P. oryzihabitans
(n = 13)
P. stutzeri
(n = 10)
P. fluorescens
(n = 5)
P. putida
(n = 4)
P. aeruginosa
(n = 3)
No. % No. % No. % No. % No. % No. % No. % No. %
Amikacin 5 27.78 5 31.25 0 0.00 2 20.00 0 0.00 0 0.00 1 33.33 13 18.84
Amoxicillin/clavulanic acid 17 94.44 13 81.25 2 15.38 10 100.00 3 60.00 1 25.00 3 100.00 49 71.00
Ampicillin 18 100.0 12 75.00 1 7.69 10 100.00 3 60.00 2 50.00 3 100.00 49 71.00
Ampicillin/sulbactam 17 94.44 3 18.75 1 7.69 10 100.00 3 60.00 2 50.00 2 66.67 38 55.00
Aztreonam 2 11.11 16 100 0 0.00 1 10.00 0 0.00 0 0.00 1 33.33 20 28.99
Cefazolin 1 5.56 0 0.00 0 0.00 0 0.00 2 40.00 0 0.00 3 100.00 6 8.70
Cefepime 3 16.67 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 1 33.33 4 5.80
Cefotaxime 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
Cefoxitin 6 33.33 12 75.00 0 0.00 10 100.00 0 0.00 0 0.00 2 66.67 20 28.99
Ceftazidime 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 1 33.33 1 1.45
Ceftriaxone 15 83.33 15 93.75 3 23.08 10 100.00 0 0.00 0 0.00 2 66.67 45 65.22
Cefuroxime 12 66.67 13 81.25 5 38.46 10 100.00 2 40.00 1 25.00 2 66.67 45 65.22
Ciprofloxacin 16 88.89 14 87.50 0 0.00 3 30.00 0 0.00 0 0.00 1 33.33 34 49.28
Gentamicin 2 11.11 4 25.00 0 0.00 2 20.00 0 0.00 0 0.00 1 33.33 9 13.04
Meropenem 7 38.89 5 31.25 2 15.38 5 50.00 0 0.00 0 0.00 1 33.33 30 43.48
Nitrofurantoin 16 88.89 15 93.75 13 100.00 10 100.00 0 0.00 0 0.00 2 66.67 56 81.16
Piperacillin/Tazobactam 1 5.56 2 12.5 0 0.00 0 0.00 0 0.00 0 0.00 1 33.33 4 5.80
Trimethoprim/Sulfamethoxazole 2 11.11 4 25.00 0 0.00 0 0.00 0 0.00 0 0.00 1 33.33 7 10.14